Product Information

RASUVO 10 MG/0.2 ML AUTOINJ is a brand product labeled by Medexus Pharma Inc., priced at $721.8144 per ML under NDC 59137051004. Its NADAC has been published 115 times since Apr 17, 2024.

The High Outlier badge above means this manufacturer's average price in the methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

RASUVO 10 MG/0.2 ML AUTOINJ

methotrexate
$721.8144per ML
High Outlier

Strength

10 mg/.2mL

NDC

59137051004

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/1/2026

Active Ingredients

METHOTREXATE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA205776

On Market Since

7/10/2014

Pharmacological Classes

Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors

Price Statistics

The NADAC for RASUVO 10 MG/0.2 ML AUTOINJ has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 5.6%. The table below summarizes its recorded NADAC range and movement.

Current price$721.8144 per ML
All-time high$721.8144 (Jun 24, 2026)
All-time low$681.8525 (Dec 18, 2024)
52-week high$721.8144
52-week low$699.9453
Median price$700.6771
Average price$696.0863
Largest weekly change+3.0% (Apr 2, 2025)
Weeks tracked115
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

+2.6%

6M

+3.1%

1Y

+2.6%

3Y

N/A

5Y

N/A

All

+5.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the methotrexate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of RASUVO 10 MG/0.2 ML AUTOINJ?

The current National Average Drug Acquisition Cost (NADAC) for RASUVO 10 MG/0.2 ML AUTOINJ, manufactured by Medexus Pharma Inc., is $721.8144 per ML (NDC 59137051004), effective Jun 24, 2026.

How has the price of RASUVO 10 MG/0.2 ML AUTOINJ changed over time?

Over the history we have for it, the NADAC for RASUVO 10 MG/0.2 ML AUTOINJ has risen 5.6%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for RASUVO 10 MG/0.2 ML AUTOINJ?

Since Apr 17, 2024, the NADAC for RASUVO 10 MG/0.2 ML AUTOINJ has ranged from a low of $681.8525 (Dec 18, 2024) to a high of $721.8144 (Jun 24, 2026), with a median of $700.6771 per ML.

Are there cheaper alternatives to RASUVO 10 MG/0.2 ML AUTOINJ?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RASUVO 10 MG/0.2 ML AUTOINJ, so no direct lower-cost alternative is listed.

Who manufactures RASUVO 10 MG/0.2 ML AUTOINJ?

RASUVO 10 MG/0.2 ML AUTOINJ (NDC 59137051004) is labeled by Medexus Pharma Inc., and CMS classifies it as a brand product.